Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Non-Current Assets (2020 - 2025)

Beauty Health (SKIN) has disclosed Non-Current Assets for 6 consecutive years, with $195.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Non-Current Assets fell 8.97% to $195.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $809.7 million, a 9.78% decrease, with the full-year FY2024 number at $208.6 million, down 9.66% from a year prior.
  • Non-Current Assets was $195.3 million for Q3 2025 at Beauty Health, down from $201.5 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $460.2 million in Q1 2021 to a low of -$748.5 million in Q1 2023.
  • A 5-year average of $172.7 million and a median of $215.6 million in 2022 define the central range for Non-Current Assets.
  • Peak YoY movement for Non-Current Assets: plummeted 445.29% in 2023, then soared 130.72% in 2024.
  • Beauty Health's Non-Current Assets stood at $217.9 million in 2021, then rose by 0.87% to $219.8 million in 2022, then grew by 5.03% to $230.9 million in 2023, then decreased by 9.66% to $208.6 million in 2024, then decreased by 6.37% to $195.3 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Non-Current Assets are $195.3 million (Q3 2025), $201.5 million (Q2 2025), and $204.4 million (Q1 2025).